CD4 and neoplasm: Moreover, FACS staining indicated that both CD4+ and CD8+ T cells expressed increased levels of the activation marker PD1, which is suggestive of tumor-specific T cells (26, 27), compared with circulating T cells (CD8+PD1+ T cells; CD4+PD1+ T cells, P < 0.05) (Figure 1F).